Arrowhead Pharmaceuticals Inc (ARWR) Insider Trading

Total insider buys:
  • $301,336.35
Total insider sells:
  • $143,830,412.54
Most recent insider trade:
  • Dec. 18, 2024
Most active insider trader:
  • Christopher Richard Anzalone
Trader NameDateTitleAmountPriceTypeTotal Value
Dec. 18, 2024CEO26,712$21.24Sell$567,362.88
Dec. 16, 2024Director3,748$21.90Sell$82,081.20
July 2, 2024Insider9,394$25.28Sell$237,480.32
May 2, 2024Director1,799$23.31Sell$41,934.69
March 20, 2024Director1,000$27.50Buy$27,500.00
March 18, 2024Director1,000$27.49Buy$27,490.00
March 6, 2024CFO40,000$35.19Sell$1,407,600.00
Jan. 31, 2024CEO57,499$32.35Sell$1,860,092.65
Jan. 12, 2024Insider7,940$36.89Sell$292,906.60
Jan. 11, 2024Director2,911$38.06Sell$110,792.66
Jan. 5, 2024Insider32,143$35.18Sell$1,130,790.74
Jan. 5, 2024CFO16,104$35.27Sell$567,988.08
Jan. 5, 2024COO22,841$35.27Sell$805,602.07
Jan. 3, 2024Insider6,300$32.19Sell$202,797.00
Jan. 3, 2024COO8,749$32.28Sell$282,417.72
Jan. 2, 2024CEO9,952$31.01Sell$308,611.52
Dec. 20, 2023CEO12,000$28.54Sell$342,480.00
Nov. 20, 2023Insider19,700$28.80Sell$567,360.00
Oct. 25, 2023CEO24,338$24.21Sell$589,222.98
Sept. 28, 2023Director1,550$26.33Sell$40,811.50
Sept. 18, 2023CEO57,755$28.12Sell$1,624,070.60
July 3, 2023Insider8,925$35.31Sell$315,141.75
June 30, 2023Insider3,000$35.53Sell$106,590.00
June 27, 2023CFO15,000$36.20Sell$543,000.00
May 5, 2023Director6,500$40.90Sell$265,850.00
May 3, 2023CEO54,928$39.14Sell$2,149,881.92
March 3, 2023Director11,350$32.65Sell$370,577.50
Feb. 27, 2023Director875$32.62Sell$28,542.50
Jan. 9, 2023Director3,200$30.00Sell$96,000.00
Jan. 5, 2023COO15,000$37.39Sell$560,850.00
Jan. 5, 2023Insider13,803$37.40Sell$516,232.20
Jan. 3, 2023Insider10,338$38.38Sell$396,772.44
Jan. 3, 2023COO17,500$38.33Sell$670,775.00
Dec. 29, 2022CFO30,625$40.00Sell$1,225,000.00
Nov. 21, 2022Insider19,500$29.99Sell$584,805.00
Feb. 11, 2022CEO146,388$51.91Sell$7,599,001.08
Jan. 5, 2022General Counsel32,500$61.72Sell$2,005,900.00
Jan. 5, 2022CFO40,000$61.70Sell$2,468,000.00
Jan. 4, 2022SVP19,375$65.49Sell$1,268,868.75
Jan. 3, 2022Director4,500$64.72Sell$291,240.00
Dec. 28, 2021Director655$66.37Buy$43,472.35
Dec. 15, 2021CEO60,000$67.56Sell$4,053,600.00
Nov. 19, 2021Insider19,500$69.31Sell$1,351,545.00
Oct. 22, 2021CEO50,000$65.63Sell$3,281,500.00
Oct. 20, 2021CEO15,000$66.23Sell$993,450.00
Sept. 13, 2021Director5,000$63.76Sell$318,800.00
June 24, 2021Director5,000$89.85Sell$449,250.00
June 22, 2021Insider3,625$89.22Sell$323,422.50
June 22, 2021Director4,500$89.21Sell$401,445.00
Feb. 8, 2021General Counsel90,000$88.46Sell$7,961,400.00
First«1 of 3»Last
  • Insiders are both buying and selling Arrowhead Pharmaceuticals Inc stock.

  • The insider traders at Arrowhead Pharmaceuticals Inc are: Christopher Richard Anzalone, Kenneth Allen Myszkowski, Bruce D Given, Patrick O'brien, Douglas B Given, James C Hamilton, Douglas B. Given, Backer Marianne De, William D Waddill, Martin Javier San, Mauro Ferrari, Michael S Perry, Adeoye Y Olukotun, Charles Mckenney, David L Lewis, Hongbo Lu, James Hassard, Tracie Oliver, Victoria Vakiener, Zhen Li, Peter Brian Leone, and Edward W Frykman

  • The most active insider trader at Arrowhead Pharmaceuticals Inc is Christopher Richard Anzalone with 29 trades.

  • Christopher Richard Anzalone has sold the most Arrowhead Pharmaceuticals Inc stock with a total value of $63,003,719.17.

  • Christopher Richard Anzalone has bought the most Arrowhead Pharmaceuticals Inc stock with a total value of $202,240.00.

  • The most recent insider trade for Arrowhead Pharmaceuticals Inc was on Dec. 18, 2024.

  • The single biggest insider buy for Arrowhead Pharmaceuticals Inc was from Christopher Richard Anzalone with a total value of $101,120.00 on Oct. 15, 2014.

  • The single biggest insider sell for Arrowhead Pharmaceuticals Inc was from Patrick O'brien with a total value of $7,961,400.00 on Feb. 8, 2021.